EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

William G. Dixon, Loreto Carmona, Axel Finckh, Merete Lund Hetland, Tore K. Kvien, Robert Landewe, Joachim Listing, Paulo J. Nicola, Ulrik Tarp, Angela Zink, Johan Askling

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1596-1602
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number9
DOIs
Publication statusPublished - Sep 2010

Cite this

Dixon, W. G., Carmona, L., Finckh, A., Hetland, M. L., Kvien, T. K., Landewe, R., Listing, J., Nicola, P. J., Tarp, U., Zink, A., & Askling, J. (2010). EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Annals of the Rheumatic Diseases, 69(9), 1596-1602. https://doi.org/10.1136/ard.2009.125526